| ED North Database | | Atrazine |
| Study details | | Group | mammalian | | Organism | Rat | | Tissue | | | Age | Prenatal | | InVivo | In vivo | | Lab | Laboratory | | Flow | | | Duration | | | Route | Subcutaneous | | Temperature | | | Concentration | 16 mg/kg bodyweight | | Notes | |
|
|
| Described effects | | suspected endocrine effect Female pups: increased 5-alpha-steroid reductase activity | | suspected no endocrine effect Female pups: no effects on pituitary androgen metabolism | | suspected endocrine effect Male pups: decreased 3-alpha-hydroxysteroid dehydrogenase and 5-alpha-steroid reductase | | suspected endocrine effect Male pups: decreased number of androgen-specific binding sites in prostate | | suspected no endocrine effect Male pups: no effects pituitary metabolism |
|
| Literature references | | Toppari,J., Larsen, J.C., Christiansen, P., Giwercman, A., Grandjean, P., Guillette, L.J., Jr., Jégou, B., Jensen, T.K., et al.(1995). Male reproductive health and environmental chemicals with estrogenic effects.Miljoprojekt nr. 290, Report of the Ministry of Environmental and Energy, Danish Environmental Protection Agency, Kobenhavn, Denmark, 166p |
|
|